Radioiodine Therapy in Patient with Differentiated Thyroid Cancer and End-Stage Renal Disease on Maintenance Hemodialysis: Case Report with Review of Literature
- PMID: 34872920
- DOI: 10.2967/jnmt.121.261979
Radioiodine Therapy in Patient with Differentiated Thyroid Cancer and End-Stage Renal Disease on Maintenance Hemodialysis: Case Report with Review of Literature
Abstract
Surgical resection followed by radioactive iodine (131I) therapy constitutes a standard treatment for differentiated thyroid cancer. 131I is normally excreted through the kidneys, and treatment of patients with end-stage renal disease on hemodialysis requires special attention to the dose of 131I, the timing of dialysis, and radiation safety. We present a case of end-stage renal disease in a postthyroidectomy patient on hemodialysis who required radioactive iodine ablation, and we review the literature.
Keywords: ESRD; radioiodine therapy; thyroid cancer.
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical